Lorazepam concentrations, pharmacokinetics and pharmacodynamics in a cohort of mechanically ventilated ICU patients

International Journal of Clinical Pharmacology and Therapeutics

Volumn 44, Issue 10, 2006, Pages 466-473

  de Wit, M ^a   Best, A M ^a   Epstein, S K ^b   Greenblatt, D J ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bispectral Index; Lorazepam; Mechanical ventilation; Pharmacokinetics; Sedation; Sedation Agitation Scale

Indexed keywords

FENTANYL; LORAZEPAM;

ADULT; AGED; ALGORITHM; ANALYSIS OF VARIANCE; ANESTHESIA LEVEL; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BISPECTRAL INDEX; BLOOD SAMPLING; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MEGADOSE; ELECTRON CAPTURE DETECTION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEDATION;

EID: 33749640664     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/cpp44466     Document Type: Article

References (26)

1. Albanese J, Martin C, Lacarelle B, Saux P, Durand A, Gouin F. Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology. 1990; 73: 214-217.
2. Allen MD, Greenblatt, DJ, LaCasse Y, Shader RI. Pharmacokinetic study of lorazepam overdosage. Am J Psychiatry. 1980; 137: 1414-1415.
3. Arbour RB. Propylene glycol toxicity related to high-dose lorazepam infusion: case report and discussion. Am J Crit Care. 1999; 8: 499-506.
4. Bailie GR, Cockshott ID, Douglas EJ, Bowles BJ. Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients. Br J Anaesthesia. 1992; 68: 486-491.
5. Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology. 2001; 95: 286-298.
6. Bodenham A, Shelly MP, Park GR. The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. Clin Pharmacokinet. 1988; 14: 347-373.
7. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, Kollef MH. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999; 27: 2609-2615.
8. Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy. 2001; 21: 1140-1144.
9. Chicella M, Jansen P, Parthiban A, Marlowe KF, Bencsath FA, Krueger KP, Boerth R. Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients. Crit Care Med. 2002; 30: 2752-2756.
10. de Wit M, Epstein SK. Administration of sedatives and level of sedation: comparative evaluation via the Sedation-Agitation Scale and the Bispectral Index. Am J Crit Care. 2003; 12: 343-348.
11. Goodman LS, Hardman JG, Limbird LE, Gilman AG. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2001.
12. Greenblatt DJ, Allen MD, Locniskar A, Harmatz JS, Shader RI. Lorazepam kinetics in the elderly. Clin Pharmacol Ther. 1979; 26: 103-113.
13. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology. 1984; 61: 27-35.
14. Greenblatt DJ, von Moltke LL, Ehrenberg BL, Harmatz JS, Corbett KE, Wallace DW, Shader RI. Kinetics and dynamics of lorazepam during and after continuous intravenous infusion. Crit Care Med. 2000; 28: 2750-2757.
15. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA,Jr, Murray MJ, Peruzzi WT, Lumb PD, Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002; 30: 119-141.
16. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998; 114: 541-548.
17. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000; 342: 1471-1477.
18. Malacrida R, Fritz ME, Suter PM, Crevoisier C. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med. 1992; 20: 1123-1126.
19. Martyn J, Greenblatt DJ. Lorazepam conjugation is unimpaired in burn trauma. Clinical Pharmacol Ther. 1988; 43: 250-255.
20. McMurray TJ, Collier PS, Carson IW, Lyons SM, Elliott P. Propofol sedation after open heart surgery. A clinical and pharmacokinetic study. Anesthesia. 1990; 45: 322-326.
21. Morgan DJ, Campbell GA, Crankshaw DP. Pharmaco-kinetics of propofol when given by intravenous infusion. Br J Clin Pharmacol. 1990; 30: 144-148.
22. Riker RR, Fraser GL, Simmons LE, Wilkins ML. Validating the Sedation-Agitation Scale with the Bispectral Index and Visual Analog Scale in adult ICU patients after cardiac surgery. Intensive Care Med. 2001; 27: 853-858.
23. Shafer A, Doze VA, White PF. Pharmacokinetic variability of midazolam infusions in critically ill patients. Crit Care Med. 1990; 18: 1039-1041.
24. Shelly, MP, Mendel, L, Park, GR. Failure of critically ill patients to metabolise midazolam. Anaesthesia. 1987; 42: 619-626.
25. Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol. 2004; 57: 135-145.
26. Wilson KC, Reardon C, Farber HW. Propylene glycol toxicity in a patient receiving intravenous diazepam. N Engl J Med. 2000; 343: 815.